---
figid: PMC9707496__fonc-12-988138-g001
figtitle: Dysregulation of FBW7 in malignant lymphoproliferative disorders
organisms:
- Mus musculus
- Human T-cell leukemia virus type I
- Human gammaherpesvirus 8
- Homo sapiens
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC9707496
filename: fonc-12-988138-g001.jpg
figlink: /pmc/articles/PMC9707496/figure/f1/
number: F1
caption: Schematic diagram of FBW7-mediated oncogene and signaling pathway in T lymphoproliferative
  malignancies. 1) Dysregulation of FBW7 can reduce cellular levels of Notch intracellular
  Domain (NICD) degradation, which leads to abnormal activation of Notch pathway,
  NF-κB pathway, and affect the expression of its downstream substrates c-Myc, cyclin
  E. 2) T-cell acute lymphocytic leukemia 1 (TAL1) can upregulate miR-223 expression,
  thus reducing the expression of FBW7 and increasing the expression of downstream
  substrates c-Myc, Notch1, cyclin E, and Mcl-1 to induce cell proliferation. 3) FBW7
  mutations activate the RAF-MEK-ERK pathway, inhibiting BRAF degradation and providing
  resistance to BET inhibitors.
papertitle: Dysregulation of FBW7 in malignant lymphoproliferative disorders.
reftext: Xin Wan, et al. Front Oncol. 2022;12:988138.
year: '2022'
doi: 10.3389/fonc.2022.988138
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.
keywords: FBW7 | lymphoproliferative disorders | ubiquitin | Notch | c-Myc
automl_pathway: 0.9535729
figid_alias: PMC9707496__F1
figtype: Figure
redirect_from: /figures/PMC9707496__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9707496__fonc-12-988138-g001.html
  '@type': Dataset
  description: Schematic diagram of FBW7-mediated oncogene and signaling pathway in
    T lymphoproliferative malignancies. 1) Dysregulation of FBW7 can reduce cellular
    levels of Notch intracellular Domain (NICD) degradation, which leads to abnormal
    activation of Notch pathway, NF-κB pathway, and affect the expression of its downstream
    substrates c-Myc, cyclin E. 2) T-cell acute lymphocytic leukemia 1 (TAL1) can
    upregulate miR-223 expression, thus reducing the expression of FBW7 and increasing
    the expression of downstream substrates c-Myc, Notch1, cyclin E, and Mcl-1 to
    induce cell proliferation. 3) FBW7 mutations activate the RAF-MEK-ERK pathway,
    inhibiting BRAF degradation and providing resistance to BET inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ptprj
  - Dner
  - Ephb2
  - Mapk1
  - Braf
  - Braf-rs1
  - Mdk
  - Fbxw7
  - Tal1
  - Mir223
  - F630028O10Rik
  - Mcl1
  - Snrpe
  - Nfkb1
  - DNER
  - EPHB2
  - MAPK1
  - MAPK3
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - FBXW7
  - TAL1
  - MIR223
  - MCL1
  - SNRPE
  - CCNE1
  - CCNE2
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - NFKB1
  - MID1
  - braf
  - si:dkey-222f8.3
  - tal1
  - mir223
---
